Evidence map›Paper›PMID 35508354›Full record

ArticleRNA (New York, N.Y.)2022

Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene.

Xueyan Liu, Xuan Liu, Jie Zhou, Yu Dong, Wen Jiang, Wenqing Jiang

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. RNA biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Mutational Landscape of SARS-CoV-2.International journal of molecular sciences · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xueyan LiuInstitute of Integrative Medicine, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266073, China.
Xuan LiuRespiratory and Critical Illness Medicine Department II, Qingdao Hiser Medical Group, Qingdao, Shandong 266033, China.
Jie ZhouNursing Department, Qingdao Central Hospital, Qingdao, Shandong 266042, China.
Yu DongInterventional Catheterization Lab, Qingdao Central Hospital, Qingdao, Shandong 266042, China.
Wen JiangRespiratory and Critical Illness Medicine Department II, Qingdao Hiser Medical Group, Qingdao, Shandong 266033, China.
Wenqing JiangRespiratory and Critical Illness Medicine Department II, Qingdao Hiser Medical Group, Qingdao, Shandong 266033, China.
Qingdao University · CNHaier Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high mutation rate of SARS-CoV-2 largely complicates our control of the pandemic. In particular, it is currently unclear why the spike (

Indexed as

COVID-19SARS-CoV-2DeaminationHumansMutationMutation RatePandemicsC-to-U deaminationmutation rateSARS-CoV-2S genesingle-stranded RNA

Identifiers

PMID35508354
PMCPMC9202584
OpenAlexW4225422125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.